Bluejay Diagnostics Inc (BJDX) stock news · rev $249.0K
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
This BJDX news page leads with what Bluejay Diagnostics Inc filed — not a scraped headline mill.
No cached 8-K sentence for BJDX yet. We will not pad this page with generic market recap.
Latest reported BJDX revenue for 2022-12-31 was $249.0K. Net income was -$9.3M. BJDX currently screens at market cap $5.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BJDX stock page; for the tape open the quote page.
BJDX stock news FAQ
What are BJDX's latest revenue and net income?
Latest cached Bluejay Diagnostics Inc (BJDX) revenue for Dec 31, 2022 was $249.0K. Net income was -$9.3M. Statements: https://lician.com/financials/bjdx
What is BJDX's market cap?
Bluejay Diagnostics Inc (BJDX) market cap is $5.0M on the latest cached fundamentals snapshot.
What kind of company is BJDX?
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
Where is BJDX stock news listed?
Cached stock news for Bluejay Diagnostics Inc (BJDX) is listed at https://lician.com/news/bjdx. Filings: https://lician.com/sec/bjdx
Not investment advice.